openPR Logo
Press release

Aethlon Medical Inc (AEMD) - Pharmaceutical Product Pipeline Analysis and Guide (2017)

09-07-2017 09:30 AM CET | Health & Medicine

Press release from: Market Research Hub - Pharmaceutical Industry

Market_Research_Hub

Market_Research_Hub

Market Research Hub (MRH) has included the latest Forecast report titled “Aethlon Medical Inc (AEMD) Product Pipeline Analysis 2017”, to its vast database. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products, and brands. The report also enhances decision-making capabilities and help to create effective counter strategies to gain competitive advantage.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1318783

Aethlon Medical Inc (Aethlon Medical) is a developer of immunotherapeutic technologies for the treatment of infectious diseases and cancer. The company’s lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, which is an enzyme linked lectin specific assay to identify and quantify the presence of exosomes in HIV, HCV and tuberculosis. The company is also developing a medical device under the DARPA Sepsis program. Aethlon harnesses it’s ADAPT system to develop infrastructure of dialysis machines and CRRT systems in hospitals and clinics. Aethlon Medical is headquartered in San Diego, California, the US.

Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Aethlon Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/aethlon-medical-inc-aemd-product-pipeline-analysis-2017-update-report.html

Table of Content:
Table of Contents 2
List of Tables 3
List of Figures 3
Aethlon Medical Inc Company Overview 4
Aethlon Medical Inc Company Snapshot 4
Aethlon Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Aethlon Medical Inc Pipeline Analysis Overview 7
Business Description 7
Aethlon Medical Inc - Key Facts 8
Aethlon Medical Inc - Major Products and Services 9
Aethlon Medical Inc Pipeline Products by Development Stage 10
Aethlon Medical Inc Ongoing Clinical Trials by Trial Status 12
Aethlon Medical Inc Pipeline Products Overview 14
ASEPSYS Device 14
ASEPSYS Device Product Overview 14
Diagnostic Test - Chronic Traumatic Encephalopathy 15
Diagnostic Test - Chronic Traumatic Encephalopathy Product Overview 15
Diagnostic Test - Chronic Traumatic Encephalopathy Clinical Trial 16
….continue

Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1318783

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aethlon Medical Inc (AEMD) - Pharmaceutical Product Pipeline Analysis and Guide (2017) here

News-ID: 702185 • Views:

More Releases from Market Research Hub - Pharmaceutical Industry

Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Players are-Abbott Laboratories, Eli Lilly, Janssen Biotech, Pfizer, Siemens and Forecast 2019-2025
Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Play …
The global market status for Enthesopathy Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Enthesopathy Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Enthesopathy Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Players:-Hologic, Hitachi, Digirad, FONAR, Covidien, Mindray and Forecast 2019-2025
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Pla …
The market for BioImaging Technologies is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global BioImaging Technologies Market Size, Status and Forecast 2019-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore,
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview 2019-2025 | Top Players are-Abbot, Pfizer, Mindray, Roche, Biorad, Siemens
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview …
Market Research Hub (MRH) has actively included a new research study titled “Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period
Global Biosimilar Testing and Development Services Market Report Overview 2019-2025 | Top Players are-Eurofins Scientific, Exova, Source BioScience, Intertek Group, Sigma-Aldrich
Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until

All 5 Releases


More Releases for Aethlon

Exosomes Development and Exosomes Manufacturing Market Key Players Analysis - 10 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Exosomes Development and Exosomes Manufacturing Market"- by Types of Service(s) Offered (Isolated Exosomes, Exosome Characterization, Purification, Chromatography, Engineering, Targeted Delivery, Diagnostic Biomarker, and Quality Control), Method of Exosome Manufacturing (Engineering and Targeted Delivery), Scale of Operation (Discovery / Research, Pre-Clinical, Clinical or Commercialized) and Scalability (Small, Mid-Sized or large) Trends, and Global Forecasts, 2022-2035 And Segment
Exosome Manufacturing Services Market Scope Growth, and Future Business Opportun …
The Global Exosome Manufacturing Services Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 28.5% from 2025 to 2032. Exosome Manufacturing Services Market Analysis - 2025-2032: Coherent Market Insights has released a new report titled "Exosome Manufacturing Services Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032 (Version 2025)." This
Exosomes Development and Exosomes Manufacturing Market Top Companies Study - 01 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Exosomes Development and Exosomes Manufacturing Market"- by Types of Service(s) Offered (Isolated Exosomes, Exosome Characterization, Purification, Chromatography, Engineering, Targeted Delivery, Diagnostic Biomarker, and Quality Control), Method of Exosome Manufacturing (Engineering and Targeted Delivery), Scale of Operation (Discovery / Research, Pre-Clinical, Clinical or Commercialized) and Scalability (Small, Mid-Sized or large) Trends, and Global Forecasts, 2022-2035 And Segment
The Rise of Exosome Therapeutics: Potential Applications and Opportunities in He …
𝐄𝐱𝐨𝐬𝐨𝐦𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐀𝐧𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 - 𝟐𝟎𝟑𝟎 The exosome diagnostic and therapeutic market size was valued at $224.34 million in 2020, and is estimated to reach $2.9 billion by 2030, growing at a CAGR of 29.4% from 2021 to 2030. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/1723 Exosomes are tiny packages released by cells that contain various molecules, such as proteins and RNA. These packages can travel through the bloodstream
Medical Membrane Devices Market Outlook and Opportunities in Grooming Regions 20 …
The report titled “Global Medical Membrane Devices MARKET “is one of the most comprehensive and important additions to market research studies. It offers detailed research and analysis of key aspects of the Medical Membrane Devices market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Medical Membrane Devices market. Market Participants can use
Exosome Diagnostic and Therapeutic Market Industry Statistics | Aethlon Medical …
Global Exosome Diagnostic and Therapeutic Market: Snapshot The demand for diagnostic and therapeutic of exosome is projected to increment at a substantial CAGR during the forecast period of 2016 to 2024, gaining traction from a number of factors such as increasing prevalence of cancer, technological advancements in exosome isolation and pertaining analytical procedures, multiple awareness initiatives implemented by the government and healthcare organizations in various developed and emerging economies, and innovative